253 related articles for article (PubMed ID: 29875732)
1. Cells of Matter-
Matloka M; Klein AF; Rau F; Furling D
Front Neurol; 2018; 9():361. PubMed ID: 29875732
[TBL] [Abstract][Full Text] [Related]
2. Mice transgenic for the human myotonic dystrophy region with expanded CTG repeats display muscular and brain abnormalities.
Seznec H; Agbulut O; Sergeant N; Savouret C; Ghestem A; Tabti N; Willer JC; Ourth L; Duros C; Brisson E; Fouquet C; Butler-Browne G; Delacourte A; Junien C; Gourdon G
Hum Mol Genet; 2001 Nov; 10(23):2717-26. PubMed ID: 11726559
[TBL] [Abstract][Full Text] [Related]
3. Myotonic dystrophy types 1 and 2.
Ashizawa T; Sarkar PS
Handb Clin Neurol; 2011; 101():193-237. PubMed ID: 21496635
[TBL] [Abstract][Full Text] [Related]
4. Chronic exercise mitigates disease mechanisms and improves muscle function in myotonic dystrophy type 1 mice.
Manta A; Stouth DW; Xhuti D; Chi L; Rebalka IA; Kalmar JM; Hawke TJ; Ljubicic V
J Physiol; 2019 Mar; 597(5):1361-1381. PubMed ID: 30628727
[TBL] [Abstract][Full Text] [Related]
5. MBNL1 and CUGBP1 modify expanded CUG-induced toxicity in a Drosophila model of myotonic dystrophy type 1.
de Haro M; Al-Ramahi I; De Gouyon B; Ukani L; Rosa A; Faustino NA; Ashizawa T; Cooper TA; Botas J
Hum Mol Genet; 2006 Jul; 15(13):2138-45. PubMed ID: 16723374
[TBL] [Abstract][Full Text] [Related]
6. Short antisense-locked nucleic acids (all-LNAs) correct alternative splicing abnormalities in myotonic dystrophy.
Wojtkowiak-Szlachcic A; Taylor K; Stepniak-Konieczna E; Sznajder LJ; Mykowska A; Sroka J; Thornton CA; Sobczak K
Nucleic Acids Res; 2015 Mar; 43(6):3318-31. PubMed ID: 25753670
[TBL] [Abstract][Full Text] [Related]
7. Myotonic dystrophy 1 in the nervous system: from the clinic to molecular mechanisms.
de León MB; Cisneros B
J Neurosci Res; 2008 Jan; 86(1):18-26. PubMed ID: 17549748
[TBL] [Abstract][Full Text] [Related]
8. Immortalized human myotonic dystrophy muscle cell lines to assess therapeutic compounds.
Arandel L; Polay Espinoza M; Matloka M; Bazinet A; De Dea Diniz D; Naouar N; Rau F; Jollet A; Edom-Vovard F; Mamchaoui K; Tarnopolsky M; Puymirat J; Battail C; Boland A; Deleuze JF; Mouly V; Klein AF; Furling D
Dis Model Mech; 2017 Apr; 10(4):487-497. PubMed ID: 28188264
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic Approaches for Dominant Muscle Diseases: Highlight on Myotonic Dystrophy.
Klein AF; Dastidar S; Furling D; Chuah MK
Curr Gene Ther; 2015; 15(4):329-37. PubMed ID: 26122101
[TBL] [Abstract][Full Text] [Related]
10. CRISPR/Cas9-Mediated Deletion of CTG Expansions Recovers Normal Phenotype in Myogenic Cells Derived from Myotonic Dystrophy 1 Patients.
Provenzano C; Cappella M; Valaperta R; Cardani R; Meola G; Martelli F; Cardinali B; Falcone G
Mol Ther Nucleic Acids; 2017 Dec; 9():337-348. PubMed ID: 29246312
[TBL] [Abstract][Full Text] [Related]
11. Expanded CUG Repeat RNA Induces Premature Senescence in Myotonic Dystrophy Model Cells.
Hasuike Y; Mochizuki H; Nakamori M
Front Genet; 2022; 13():865811. PubMed ID: 35401669
[TBL] [Abstract][Full Text] [Related]
12. Myotonic dystrophy: emerging mechanisms for DM1 and DM2.
Cho DH; Tapscott SJ
Biochim Biophys Acta; 2007 Feb; 1772(2):195-204. PubMed ID: 16876389
[TBL] [Abstract][Full Text] [Related]
13. Expanded CCUG repeat RNA expression in Drosophila heart and muscle trigger Myotonic Dystrophy type 1-like phenotypes and activate autophagocytosis genes.
Cerro-Herreros E; Chakraborty M; Pérez-Alonso M; Artero R; Llamusí B
Sci Rep; 2017 Jun; 7(1):2843. PubMed ID: 28588248
[TBL] [Abstract][Full Text] [Related]
14. Targeting DMPK with Antisense Oligonucleotide Improves Muscle Strength in Myotonic Dystrophy Type 1 Mice.
Jauvin D; Chrétien J; Pandey SK; Martineau L; Revillod L; Bassez G; Lachon A; MacLeod AR; Gourdon G; Wheeler TM; Thornton CA; Bennett CF; Puymirat J
Mol Ther Nucleic Acids; 2017 Jun; 7():465-474. PubMed ID: 28624222
[TBL] [Abstract][Full Text] [Related]
15. [Pathogenesis of myotonic dystrophy type 1].
Magaña JJ; Leyva-García N; Cisneros B
Gac Med Mex; 2009; 145(4):331-7. PubMed ID: 20073433
[TBL] [Abstract][Full Text] [Related]
16. Pentamidine rescues contractility and rhythmicity in a Drosophila model of myotonic dystrophy heart dysfunction.
Chakraborty M; Selma-Soriano E; Magny E; Couso JP; Pérez-Alonso M; Charlet-Berguerand N; Artero R; Llamusi B
Dis Model Mech; 2015 Dec; 8(12):1569-78. PubMed ID: 26515653
[TBL] [Abstract][Full Text] [Related]
17. Molecular and clinical characteristics of myotonic dystrophy type 1 in koreans.
Kim SY; Kim JY; Kim GP; Sung JJ; Lim KS; Lee KW; Chae JH; Hong YH; Seong MW; Park SS
Korean J Lab Med; 2008 Dec; 28(6):483-92. PubMed ID: 19127114
[TBL] [Abstract][Full Text] [Related]
18. Furamidine Rescues Myotonic Dystrophy Type I Associated Mis-Splicing through Multiple Mechanisms.
Jenquin JR; Coonrod LA; Silverglate QA; Pellitier NA; Hale MA; Xia G; Nakamori M; Berglund JA
ACS Chem Biol; 2018 Sep; 13(9):2708-2718. PubMed ID: 30118588
[TBL] [Abstract][Full Text] [Related]
19. Muscle wasting in myotonic dystrophies: a model of premature aging.
Mateos-Aierdi AJ; Goicoechea M; Aiastui A; Fernández-Torrón R; Garcia-Puga M; Matheu A; López de Munain A
Front Aging Neurosci; 2015; 7():125. PubMed ID: 26217220
[TBL] [Abstract][Full Text] [Related]
20. Muscleblind localizes to nuclear foci of aberrant RNA in myotonic dystrophy types 1 and 2.
Mankodi A; Urbinati CR; Yuan QP; Moxley RT; Sansone V; Krym M; Henderson D; Schalling M; Swanson MS; Thornton CA
Hum Mol Genet; 2001 Sep; 10(19):2165-70. PubMed ID: 11590133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
